Non-myeloablative regimen consisting of busulfan, fludarabine, and ATG for allogeneic peripheral blood stem cell transplantation.

被引：0
|
作者：
Mayer, J [1 ]
Koristek, Z [1 ]
Krahulová, M [1 ]
Vorlicek, J [1 ]
机构：
[1] Masaryk Univ Hosp, Brno, Czech Republic
来源：
EXPERIMENTAL HEMATOLOGY | 1999年 / 27卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
361
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [41] Quality of life in patients undergoing non-myeloablative (NST) versus myeloablative (MT) allogeneic peripheral blood stem cell transplantation (PBSCT).
    Bevans, M
    Marden, S
    Leidy, N
    Soeken, K
    Rivera, P
    Cusack, G
    Mayberry, H
    Bishop, M
    Barrett, J
    BLOOD, 2003, 102 (11) : 722A - 722A
  • [42] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    Iravani, M.
    Evazi, M. R.
    Mousavi, S. A.
    Shamshiri, A. R.
    Tavakoli, M.
    Ashouri, A.
    Samiee, S.
    Chahardovali, B.
    Alimoghaddam, K.
    Ghaffari, S. H.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 105 - 110
  • [43] T-cell replete non-myeloablative allogeneic peripheral blood stem cell transplantation from HLA haploidentical family donors after preparation using busulfan, fludarabine and anti-thymocyte globulin
    Kim, C. S.
    Kim, I.
    Yi, H. G.
    Park, Y. H.
    Yoon, S. S.
    Park, S.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S525 - S526
  • [44] Incidence and outcome of thrombotic microangiopathy after allogeneic peripheral blood stem cell transplantation with non-myeloablative conditioning compared with myeloablative conditioning
    Willems, E
    Baron, F
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 : S46 - S46
  • [45] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    M Iravani
    M R Evazi
    S A Mousavi
    A R Shamshiri
    M Tavakoli
    A Ashouri
    S Samiee
    B Chahardovali
    K Alimoghaddam
    S H Ghaffari
    A Ghavamzadeh
    Bone Marrow Transplantation, 2007, 40 : 105 - 110
  • [46] Kinetic of clearance of bcr/abl-positive cells after a non-myeloablative regimen containing busulfan, fludarabine, and ATG.
    Mayer, J
    Dvorakova, D
    Brychtova, Y
    Krahulova, M
    Koristek, Z
    Freiberger, T
    BONE MARROW TRANSPLANTATION, 2001, 27 : S286 - S286
  • [47] Non-myeloablative peripheral blood stem cell transplantation for chronic myelogenous leukemia.
    Sloand, EM
    Childs, RW
    Greene, A
    Phang, S
    Young, NS
    Barrett, J
    BLOOD, 2000, 96 (11) : 783A - 783A
  • [48] Non-Myeloablative Stem Cell Transplantation
    Robert Marcus
    Bone Marrow Transplantation, 2001, 27 (6) : 667 - 667
  • [49] Engraftment of allogeneic T-cell depleted peripheral blood stem cell transplantation after non-myeloablative conditioning regiment
    Kreiter, S
    Schuler, M
    Kolbe, K
    Després, D
    Huber, C
    Derigs, HG
    BONE MARROW TRANSPLANTATION, 1999, 23 : S22 - S22
  • [50] Successful non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT) for Waldenstrom's macroglobulinemia with severe pancytopenia
    Ueda, T
    Hatanaka, K
    Kosugi, S
    Kishino, BI
    Tamaki, T
    BONE MARROW TRANSPLANTATION, 2001, 28 (06) : 609 - 611
12345